We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ferromagnetic Nanoparticles Used in New Immunoassays

By HospiMedica staff writers
Posted on 22 Oct 2007
Immunoassays have been developed based on the peroxidase activity of ferric oxide (Fe3O4) magnetic nanoparticles (MNPs).

The nanoparticles are active catalysts, and the catalytic activity is greater in smaller particles. More...
In addition, iron oxide nanoparticles are more stable over a variety of temperatures and varying levels of acidity, giving them an additional advantage over the traditional horseradish peroxidase that is used in the enzyme-linked immunosorbant assay (ELISA).

Most immunoassays are ELISAs. Because it can evaluate the presence of an antigen or antibody in a sample, the ELISA is commonly used to test for human immunodeficiency virus (HIV), hepatitis B, and West Nile Virus. The test basically involves an antigen attached to a solid surface. When the antibody is washed over the surface, it binds to the antigen. The antibody is then linked to an enzyme, usually a peroxidase, which reacts with certain substrates, resulting in a change in color. The evolution of immunoassays has continued with developments such as the fluorimetric immunoassay.

Prof. Xiyun Yan from the National Laboratory of Biomacromolecules in the Institute of Biophysics of the Chinese Academy of Sciences (CAS; Beijing, PR China), and colleagues showed that iron oxide nanoparticles are intrinsically active catalysts for oxidation reactions.

"The magnetic properties allow separation of the target from a complex solution, and the peroxidase assay can then be used to detect and quantify the amount of the target molecule,” said Prof. Yan. According to the CAS scientists, magnetic ELISA assays are already widely used for laboratory and diagnostic purposes. However, the difference when using the intrinsic activity of the MNPs compared to the traditional ELISA, is that there is no need for the binding step with a secondary, enzyme-counjugated antibody.

Prof. Yan and her collaborators have already developed two novel immunoassays (one for hepatitis B and the other for myocardial infarction) that exploit this new discovery. Using the appropriate antibody, the nanoparticles capture the target molecule in solution and then a magnet is used to isolate the nanoparticles. With the simple addition of a peroxidase-sensitive dye, the solution changes from clear to blue in the presence of the nanoparticles.

According to the scientists, the stability, ease of production, and versatility of the iron oxide nanoparticles makes them a powerful tool for a wide range of potential applications in clinical diagnostics, biotechnology, and environmental chemistry.

"The MNP assay would be worth developing commercially, because it is cheaper, faster, more direct, and potentially more sensitive,” said Prof. Yan. "… we are already collaborating with a company to develop the MNP-based immunoassay and to apply MNPs for the treatment of wastewater. The magnetic properties allow separation of the target from a complex solution and the peroxidase assay can then be used to detect and quantify the amount of the target molecule.”

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
OR Table Accessory
Angular Accessory Rail
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.